ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links5 made here, not in the record8 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05195619Personalized DC Vaccines inNon Small Cell Lung CancerCentre Hospitalier UniversitaiPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSINT010911Entry “Autologous dendritic cell vacc…›Nov 18 · Rule based · BackgroundBackgroundCyclophosphamideEntry “Low dose cyclophosphamide”, re…›Nov 18 · Rule based · TestedTestedPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · BackgroundBackgroundNivolumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · BackgroundBackgroundAtezolizumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundOsimertinibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundAlectinibMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · Background · careBackground · care

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT05195619gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 8:22 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Pembrolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 2Nivolumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Atezolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Osimertinibmade hereClaude Opus 5.5BackgroundCurrent
Nov 10Alectinibmade hereClaude Opus 5.5Background · careCurrent
Nov 18INT010911Rule based · role ruleBackgroundCurrent
Nov 18CyclophosphamideRule based · role ruleTestedCurrent
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.